EMPIRI INC.

A startup biotechnology platform company currently focused on precision oncology. EMPIRI is revolutionizing the way we treat cancer by providing empirical, personalized drug response data before treatments are selected for each patient by oncologists. We are building LDTs for specific cancer indications and a first-in-class automated cancer diagnostic instrument to scale our assays. We are also a 10x Genomic Certified Service Provider for single-cell analysis for clinical and preclinical studies.